414 related articles for article (PubMed ID: 24136239)
21. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
22. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
[No Abstract] [Full Text] [Related]
23. Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia.
Hillemanns P; Petry KU; Soergel P; Collinet P; Ardaens K; Gallwas J; Luyten A; Dannecker C
Lasers Surg Med; 2014 Aug; 46(6):456-61. PubMed ID: 24799181
[TBL] [Abstract][Full Text] [Related]
24. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
Niu XY; Feng YK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP].
Chen LM; Liu L; Tao X; He Y; Guo LP; Zhang HW; Zhou XR; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):534-540. PubMed ID: 31461810
[No Abstract] [Full Text] [Related]
26. Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins.
Ayhan A; Tuncer HA; Reyhan NH; Kuscu E; Dursun P
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():1-6. PubMed ID: 27038228
[TBL] [Abstract][Full Text] [Related]
27. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
Hillemanns P; Garcia F; Petry KU; Dvorak V; Sadovsky O; Iversen OE; Einstein MH
Am J Obstet Gynecol; 2015 Apr; 212(4):465.e1-7. PubMed ID: 25467012
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy for cervical intraepithelial neoplasia.
Yamaguchi S; Tsuda H; Takemori M; Nakata S; Nishimura S; Kawamura N; Hanioka K; Inoue T; Nishimura R
Oncology; 2005; 69(2):110-6. PubMed ID: 16118506
[TBL] [Abstract][Full Text] [Related]
29. Loop electrosurgical excision procedure followed by 5-aminolevulinic acid photodynamic therapy for cervical intraepithelial neoplasia, a report of six cases.
Cai H; Ma T; Che Y; Wang Y; Wang C; Yin G
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101650. PubMed ID: 31923634
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia: a systemic review.
Tao XH; Guan Y; Shao D; Xue W; Ye FS; Wang M; He MH
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):104-12. PubMed ID: 24631593
[TBL] [Abstract][Full Text] [Related]
31. Management of patients with positive margin after conization for high-grade cervical intraepithelial lesions.
Zhang Y; Su Y; Tang Y; Qin L; Shen Y; Wang B; Zhou Y; Zhang M; Zhang T
Lasers Surg Med; 2022 Oct; 54(8):1099-1106. PubMed ID: 35811501
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 5-ALA-PDT and LEEP of cervical squamous intraepithelial neoplasia (CIN2) with high-risk human papillomavirus infection in childbearing age women: A non-randomized controlled polit study.
Wang L; Liu X; Zhang J; Song M; Liu H; Xu Y; Meng L; Zhang Y; Jia L
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104044. PubMed ID: 38467338
[TBL] [Abstract][Full Text] [Related]
33. [Photodynamic therapy (PDT) for early cervical cancer].
Muroya T; Suehiro Y; Umayahara K; Akiya T; Iwabuchi H; Sakunaga H; Sakamoto M; Sugishita T; Tenjin Y
Gan To Kagaku Ryoho; 1996 Jan; 23(1):47-56. PubMed ID: 8546469
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of 5-aminolevulinic acid and LED photodynamic therapy in cervical intraepithelial neoplasia: A clinical trial.
Mizuno M; Mitsui H; Kajiyama H; Teshigawara T; Inoue K; Takahashi K; Ishii T; Ishizuka M; Nakajima M; Kikkawa F
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102004. PubMed ID: 33022421
[TBL] [Abstract][Full Text] [Related]
35. High-risk HPV clearance and CIN 3 treated with MAL-PDT: A case report.
de Castro CA; Lombardi W; Stringasci MD; Bagnato VS; Inada NM
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101937. PubMed ID: 32739622
[TBL] [Abstract][Full Text] [Related]
36. HPV determination in the control after LEEP due to CIN II-III: prospective study and predictive model.
Fuste P; Bellosillo B; Santamaria X; Mancebo G; Mariñoso L; Alameda F; Espinet B; Sole F; Serrano S; Carreras R
Int J Gynecol Pathol; 2009 Mar; 28(2):120-6. PubMed ID: 19188824
[TBL] [Abstract][Full Text] [Related]
37. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses.
Maluf PJ; Adad SJ; Murta EF
Tumori; 2004; 90(5):473-7. PubMed ID: 15656332
[TBL] [Abstract][Full Text] [Related]
38. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
39. Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity.
Soergel P; Makowski L; Makowski E; Schippert C; Hertel H; Hillemanns P
Lasers Surg Med; 2011 Sep; 43(7):713-20. PubMed ID: 22057499
[TBL] [Abstract][Full Text] [Related]
40. Successful pregnancy and delivery after HiPorfin photodynamic therapy for cervical high-grade squamous intraepithelial lesion.
Liu Y; Wu R; Li C; Wei L; Li R
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104062. PubMed ID: 38527659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
